China NMPA Product Recall - Gene sequencer

On May 22, 2023, the National Medical Products Administration (NMPA) announced a Level II voluntary recall initiated by Illumina Inc., specifically involving its gene sequencers (National Medical Device Registration Certificate No. 20183400291), through its entity, Illumina (China) Scientific Instruments Co., Ltd. This critical action stems from the identification of a significant cybersecurity vulnerability affecting these medical devices. The core issue is the potential for this vulnerability to lead to inaccurate analytical results from the instruments, thereby impacting diagnostic reliability. Furthermore, the vulnerability presents a notable risk to the security of sensitive data generated and stored by the sequencers. In response to these potential threats to patient safety and data integrity, Illumina Inc. has taken the necessary step of recalling the affected products. The company is coordinating this recall under the oversight of the NMPA, with comprehensive details regarding specific product models, specifications, and implicated batches provided in the accompanying 'Medical Device Recall Event Report Form' to facilitate the process and ensure all affected devices are addressed.